02617.HK
TransThera Sciences (Nanjing) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 10.15
+0.59%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 98.75x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.93x
- Price / sales
- 98.75x
- Price / cash flow
- -23.90x
Enterprise value
- Enterprise value
- HKD 3.0B
- EV / sales
- 72.45x
- EV / EBITDA
- -9.47x
- EV / EBIT
- -6.39x
- Market cap
- HKD 4.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026